{
  "type": "hyp",
  "text": "In a human malignant melanoma study NM23.H1 gene expression was found to be significantly lower in metastases that developed less than 24 months after diagnosis of the primary tumours.\n",
  "self": {
    "NER": {
      "answers": [
        "less than 24 months"
      ],
      "QG_hash=ThomasNLG/t5-qg_squad1-en": {
        "questions": [
          "How long after diagnosis did NM23.H1 gene expression decrease?"
        ]
      }
    },
    "NOUN": {
      "answers": [
        "a human malignant melanoma study",
        "gene expression",
        "metastases",
        "less than 24 months",
        "diagnosis",
        "the primary tumours"
      ],
      "QG_hash=ThomasNLG/t5-qg_squad1-en": {
        "questions": [
          "In what study was NM23.H1 gene expression found to be significantly lower in met",
          "What was found to be significantly lower in metastases that developed less than 24 months after diagnosis",
          "What type of tumors did the NM23.H1 gene expression decrease in?",
          "How long after diagnosis did NM23.H1 gene expression decrease?",
          "What was the primary tumor?",
          "What was the NM23.H1 gene found to be significantly lower in metastases"
        ]
      }
    }
  },
  "asked": {
    "What is the name of the gene that identifies high malignancy human melano": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "NM23.H1",
        "answerability": 0.7093751430511475,
        "ground_truth": {
          "A low NM23.H1 gene expression": {
            "bertscore": 0.7778578400611877,
            "f1": 0.4
          }
        }
      }
    },
    "What does NM23.H1 gene expression identify?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "unanswerable",
        "answerability": 0.09319406747817993,
        "ground_truth": {
          "high malignancy human melanomas": {
            "bertscore": 0.6429732441902161,
            "f1": 0
          }
        }
      }
    }
  }
}